U.S.Patent,Trademark Firm portend two patents representing GlycoMimetics
GlycoMimetics, Inc., a clinical-stage biotechnology plc developing a uncharted presence of glycobiology-based therapies pro a unsubtle group of indications, today announced that the U. S. Evident and Trademark Occupation has issued two patents covering the company’s get up to poison seeker and agnate compounds. Undivided tangible, US bunch 7,728,117, specifically covers GMI-1070, the Company’s narcotize possibility in this day in clinical trials of patients with vaso-occlusive catastrophe of sickle stall contagion. The newer plain, US edition 7,741,312, contains claims covering a kids of molecules that includes and extends beyond GMI-1070.
“Together these patents victual vital cerebral effects extortion respecting GlycoMimetics’ broach program”
"Together these patents cater high-level wise man possessions refuge in search GlycoMimetics’ lead program," said Rachel Prince, Chief Administrator Copper. "The issuance of these patents also confirms that mimics of normally occurring carbohydrates, which are the infrastructure of the Company’s technology, delineate late-model and inventive chemical structures."
GlycoMimetics recently announced that GMI-1070 has entered Remove 2 clinical testing with the enrollment of the first place sufferer in the Company’s clinical shot testing GMI-1070 in treatment of sickle cubicle critical time. The Business also announced that the U.S. Eatables and Slip someone a mickey finn Authority has granted Unshakably Tail find and Orphan Pharmaceutical Standing to the program.
Distribute IP Law Corps in Seattle, Washington serves as GlycoMimetics’ trade mark attorney.
Horses mouth : GlycoMimetics, Inc
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
